CYP1A1 MspI polymorphism and susceptibility to lung cancer in the Chinese population: an updated meta-analysis and review
- PMID: 26550103
- PMCID: PMC4612788
CYP1A1 MspI polymorphism and susceptibility to lung cancer in the Chinese population: an updated meta-analysis and review
Abstract
Background: Although many epidemiologic studies have investigated the CYP1A1 MspI gene polymorphisms and their associations with lung cancer (LC), definite conclusions cannot be drawn.
Objective: To clarify the effects of CYP1A1 MspI polymorphisms on the risk of LC, an update meta-analysis was performed in only Chinese population.
Methods: Related studies were identified from PubMed, Springer Link, Ovid, Chinese Wanfang Data Knowledge Service Platform, Chinese National Knowledge Infrastructure (CNKI), and Chinese Biology Medicine (CBM) till October 2014. Pooled ORs and 95% CIs were used to assess the strength of the associations.
Results: A total of 22 studies including 3016 LC cases and 3932 controls were involved in this meta-analysis. Overall, significant association was found between CYP1A1 MspI polymorphism and LC risk when all studies in the Chinese population pooled into this meta-analysis (CC vs. TT: OR = 1.42, 95% CI = 1.11-1.80; CT + CC vs. TT: OR = 1.26, 95% CI = 1.06-1.50; CC vs. CT + TT: OR = 1.30, 95% CI = 1.04-1.61; C vs. T: OR = 1.21, 95% CI = 1.07-1.37). In subgroup analyses stratified by ethnicity and source of controls, significantly increased risk was found in Chinese Han people and in population-based studies.
Conclusions: This meta-analysis provides the evidence that CYP1A1 MspI polymorphism may contribute to the LC development in the Chinese population and studies with large sample size and wider spectrum of population are warranted to verify this finding.
Keywords: CYP1A1 MspI; Chinese; Meta-analysis; lung cancer; polymorphism.
Figures
Similar articles
-
Association of CYP1A1 MspI polymorphism in the esophageal cancer risk: a meta-analysis in the Chinese population.Eur J Med Res. 2015 Mar 30;20(1):46. doi: 10.1186/s40001-015-0135-3. Eur J Med Res. 2015. PMID: 25886559 Free PMC article.
-
Cytochrome P450 1A1 exon 7 polymorphism and susceptibility to lung cancer in the Chinese population: an updated meta-analysis and review.Onco Targets Ther. 2015 Jul 2;8:1611-8. doi: 10.2147/OTT.S84575. eCollection 2015. Onco Targets Ther. 2015. PMID: 26170697 Free PMC article.
-
Methylenetetrahydrofolate reductase 677TT genotype may be associated with an increased lung cancer risk in North China: an updated meta-analysis.Med Sci Monit. 2014 Dec 29;20:2817-23. doi: 10.12659/MSM.892050. Med Sci Monit. 2014. PMID: 25544260 Free PMC article.
-
Association of the Aldose Reductase-106TT Genotype with Increased Risk for Diabetic Retinopathy in the Chinese Han Population: An Updated Meta-Analysis.Curr Eye Res. 2016 Aug;41(8):1087-1091. doi: 10.3109/02713683.2015.1084642. Epub 2015 Nov 18. Curr Eye Res. 2016. PMID: 26580232 Review.
-
GSTT1 polymorphism and breast cancer risk in the Chinese population: an updated meta-analysis and review.Int J Clin Exp Med. 2015 May 15;8(5):6650-7. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26221202 Free PMC article. Review.
Cited by
-
Molecular mechanisms of pulmonary carcinogenesis by polycyclic aromatic hydrocarbons (PAHs): Implications for human lung cancer.Semin Cancer Biol. 2021 Nov;76:3-16. doi: 10.1016/j.semcancer.2021.07.001. Epub 2021 Jul 7. Semin Cancer Biol. 2021. PMID: 34242741 Free PMC article. Review.
References
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, Gao YT, Gupta PC, Hackshaw A, Matos E, Samet J, Sitas F, Smith J, Stayner L, Straif K, Thun MJ, Wichmann HE, Wu AH, Zaridze D, Peto R, Doll R. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst. 2004;96:99–106. - PubMed
-
- Osann KE. Epidemiology of lung cancer. Curr Opin Pulm Med. 1998;4:198–204. - PubMed
-
- Hecht SS. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol. 2002;3:461–469. - PubMed
Publication types
LinkOut - more resources
Full Text Sources